Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Ultrasound imaging in the management of clinical neonatal hip instability - a randomised controlled trial
ISRCTN ISRCTN65859742
DOI 10.1186/ISRCTN65859742
ClinicalTrials.gov identifier
EudraCT number
Public title Ultrasound imaging in the management of clinical neonatal hip instability - a randomised controlled trial
Scientific title
Acronym The Hip Trial
Serial number at source G9312055
Study hypothesis To assess the clinical effectiveness and cost effectiveness of a policy of ultrasound imaging to guide the decision about whether to initiate treatment for clinical hip instability in neonates. In particular the trial will assess whether the reduction in the use of splinting following ultrasound diagnosis is associated with an increased need for late treatment
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Neonatal hip instability
Participants - inclusion criteria Babies less than 6 weeks old with a clinical suspicion of neonatal hip instability
1. Suspicion confirmed by a second doctor
2. There is clinical uncertainty about whether the decision to initiate treatment should be guided by ultrasound examination
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/12/1994
Anticipated end date 01/01/2001
Status of trial Completed
Patient information material
Target number of participants 629
Interventions Ultrasound imaging to guide the decision about whether to initiate treatment for clinical hip instability in neonates/control.
Primary outcome measure(s) X-ray appearance between 12 and 24 months used as a measure of hip function, proportion of babies splinted; proportion of babies needing surgery; financial burden on families and the health services; pyschosocial impact on families
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (UK) (ref: G9312055)
Trial website
Publications 1. 2002 results in http://www.ncbi.nlm.nih.gov/pubmed/12504396
2. 2005 results in http://www.ncbi.nlm.nih.gov/pubmed/15613565
Contact name Prof  Diana  Elbourne
  Address Medical Statistics Unit
London School of Hygiene and Tropical Medicine
Keppel Street
  City/town London
  Zip/Postcode WC1E 7HT
  Country United Kingdom
  Tel +44 (0)20 7927 2629
  Fax +44 (0)20 7637 2853
  Email diana.elbourne@lshtm.ac.uk
Sponsor Medical Research Council (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 25/10/2000
Last edited 15/01/2009
Date ISRCTN assigned 25/10/2000
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.